Login
Home
Charts
Search
Watchlist
Products

Kovai Medical Center & Hospital Ltd

KOVAI·NSE
6,153.50-0.41%Tue, 22 Sept '26 15:53

Kovai Medical Center & Hospital Ltd

KOVAI
NSE
6,153.50
-0.41%
|Tue, 22 Sept '26 15:53
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
6,698Cr
Close
Close Price
6,121.50
Industry
Industry
Hospitals
PE
Price To Earnings
26.13
PS
Price To Sales
4.07
Revenue
Revenue
1,644Cr
Rev Gr TTM
Revenue Growth TTM
14.97%
PAT Gr TTM
PAT Growth TTM
16.29%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
303321321315344355357374392407414431
Growth YoY
Revenue Growth YoY%
19.921.420.314.713.610.611.218.714.014.615.915.3
Expenses
ExpensesCr
217225229229248252256268285291303307
Operating Profit
Operating ProfitCr
8596928696103101106107116111124
OPM
OPM%
28.230.028.627.427.829.028.328.327.328.526.828.7
Other Income
Other IncomeCr
456556666787
Interest Expense
Interest ExpenseCr
877789999868
Depreciation
DepreciationCr
232324242425252627282932
PBT
PBTCr
587167616775747678878492
Tax
TaxCr
151715151717201919222122
PAT
PATCr
435352465158555759656369
Growth YoY
PAT Growth YoY%
43.470.570.847.316.88.84.825.116.112.515.820.7
NPM
NPM%
14.316.516.314.514.716.315.315.315.016.015.316.0
EPS
EPS
39.748.547.741.846.352.850.052.353.859.457.963.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
303321321315344355357374392407414431
Growth YoY
Revenue Growth YoY%
19.921.420.314.713.610.611.218.714.014.615.915.3
Expenses
ExpensesCr
217225229229248252256268285291303307
Operating Profit
Operating ProfitCr
8596928696103101106107116111124
OPM
OPM%
28.230.028.627.427.829.028.328.327.328.526.828.7
Other Income
Other IncomeCr
456556666787
Interest Expense
Interest ExpenseCr
877789999868
Depreciation
DepreciationCr
232324242425252627282932
PBT
PBTCr
587167616775747678878492
Tax
TaxCr
151715151717201919222122
PAT
PATCr
435352465158555759656369
Growth YoY
PAT Growth YoY%
43.470.570.847.316.88.84.825.116.112.515.820.7
NPM
NPM%
14.316.516.314.514.716.315.315.315.016.015.316.0
EPS
EPS
39.748.547.741.846.352.850.052.353.859.457.963.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4655315886287126909051,0201,2201,3711,5861,644
Growth
Revenue Growth%
15.914.110.86.813.3-3.031.112.619.612.415.715.0
Expenses
ExpensesCr
3744064594965444976487518789851,1471,186
Operating Profit
Operating ProfitCr
92125129132168193257269342386439458
OPM
OPM%
19.723.522.021.123.628.028.426.328.028.127.727.9
Other Income
Other IncomeCr
86781112131621222829
Interest Expense
Interest ExpenseCr
171513121531434033333231
Depreciation
DepreciationCr
21243436526885899298109115
PBT
PBTCr
62928993112106141155238278326341
Tax
TaxCr
223231331728363958698185
PAT
PATCr
406058609578104116180209244256
Growth
PAT Growth%
4.548.3-3.33.757.3-17.934.211.055.316.317.016.3
NPM
NPM%
8.711.39.89.613.311.311.511.314.715.215.415.6
EPS
EPS
37.054.853.055.086.471.095.3105.8164.3190.9223.4234.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4655315886287126909051,0201,2201,3711,5861,644
Growth
Revenue Growth%
15.914.110.86.813.3-3.031.112.619.612.415.715.0
Expenses
ExpensesCr
3744064594965444976487518789851,1471,186
Operating Profit
Operating ProfitCr
92125129132168193257269342386439458
OPM
OPM%
19.723.522.021.123.628.028.426.328.028.127.727.9
Other Income
Other IncomeCr
86781112131621222829
Interest Expense
Interest ExpenseCr
171513121531434033333231
Depreciation
DepreciationCr
21243436526885899298109115
PBT
PBTCr
62928993112106141155238278326341
Tax
TaxCr
223231331728363958698185
PAT
PATCr
406058609578104116180209244256
Growth
PAT Growth%
4.548.3-3.33.757.3-17.934.211.055.316.317.016.3
NPM
NPM%
8.711.39.89.613.311.311.511.314.715.215.415.6
EPS
EPS
37.054.853.055.086.471.095.3105.8164.3190.9223.4234.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1111111111111111111111
Reserves
ReservesCr
1652242763324204995987088781,0751,308
Current Liabilities
Current LiabilitiesCr
9296106121105139163185203270327
Non Current Liabilities
Non Current LiabilitiesCr
162132212385571633570538347444420
Total Liabilities
Total LiabilitiesCr
4304646058501,1071,2811,3431,4421,4381,8002,066
Current Assets
Current AssetsCr
7192121129142188238299250331421
Non Current Assets
Non Current AssetsCr
3593724847209651,0931,1051,1431,1881,4691,645
Total Assets
Total AssetsCr
4304646058501,1071,2811,3431,4421,4381,8002,066
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1111111111111111111111
Reserves
ReservesCr
1652242763324204995987088781,0751,308
Current Liabilities
Current LiabilitiesCr
9296106121105139163185203270327
Non Current Liabilities
Non Current LiabilitiesCr
162132212385571633570538347444420
Total Liabilities
Total LiabilitiesCr
4304646058501,1071,2811,3431,4421,4381,8002,066
Current Assets
Current AssetsCr
7192121129142188238299250331421
Non Current Assets
Non Current AssetsCr
3593724847209651,0931,1051,1431,1881,4691,645
Total Assets
Total AssetsCr
4304646058501,1071,2811,3431,4421,4381,8002,066

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
859987126166186262263344335362
Investing Cash Flow
Investing Cash FlowCr
-65-32-123-277-268-180-99-127-138-334-230
Financing Cash Flow
Financing Cash FlowCr
-24-506016011338-119-86-24362-58
Net Cash Flow
Net Cash FlowCr
-51724911444450-386373
Free Cash Flow
Free Cash FlowCr
1463-41-151-1025163136206-18111
CFO To PAT
CFO To PAT%
209.3164.7150.0209.6175.7239.1251.1227.1191.5160.1148.0
CFO To EBITDA
CFO To EBITDA%
92.379.267.295.398.996.1101.997.9100.786.882.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
859987126166186262263344335362
Investing Cash Flow
Investing Cash FlowCr
-65-32-123-277-268-180-99-127-138-334-230
Financing Cash Flow
Financing Cash FlowCr
-24-506016011338-119-86-24362-58
Net Cash Flow
Net Cash FlowCr
-51724911444450-386373
Free Cash Flow
Free Cash FlowCr
1463-41-151-1025163136206-18111
CFO To PAT
CFO To PAT%
209.3164.7150.0209.6175.7239.1251.1227.1191.5160.1148.0
CFO To EBITDA
CFO To EBITDA%
92.379.267.295.398.996.1101.997.9100.786.882.5

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7611,4391,3688437441,2061,7452,0144,0945,6675,4956,698
Price To Earnings
Price To Earnings
19.124.023.614.07.915.516.717.422.827.122.526.1
Price To Sales
Price To Sales
1.62.72.31.31.11.81.92.03.44.13.54.1
Price To Book
Price To Book
4.36.14.82.51.72.42.92.84.65.24.25.1
EV To EBITDA
EV To EBITDA
9.111.711.18.27.08.78.28.512.315.112.715.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
40.644.443.943.945.949.448.948.350.050.551.351.3
OPM
OPM%
19.723.522.021.123.628.028.426.328.028.127.727.9
NPM
NPM%
8.711.39.89.613.311.311.511.314.715.215.415.6
ROCE
ROCE%
26.132.922.615.313.112.115.915.922.620.720.820.8
ROE
ROE%
23.025.520.217.521.915.217.116.120.219.218.518.5
ROA
ROA%
9.412.99.67.18.56.17.88.012.511.611.811.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7611,4391,3688437441,2061,7452,0144,0945,6675,4956,698
Price To Earnings
Price To Earnings
19.124.023.614.07.915.516.717.422.827.122.526.1
Price To Sales
Price To Sales
1.62.72.31.31.11.81.92.03.44.13.54.1
Price To Book
Price To Book
4.36.14.82.51.72.42.92.84.65.24.25.1
EV To EBITDA
EV To EBITDA
9.111.711.18.27.08.78.28.512.315.112.715.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
40.644.443.943.945.949.448.948.350.050.551.351.3
OPM
OPM%
19.723.522.021.123.628.028.426.328.028.127.727.9
NPM
NPM%
8.711.39.89.613.311.311.511.314.715.215.415.6
ROCE
ROCE%
26.132.922.615.313.112.115.915.922.620.720.820.8
ROE
ROE%
23.025.520.217.521.915.217.116.120.219.218.518.5
ROA
ROA%
9.412.99.67.18.56.17.88.012.511.611.811.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Kovai Medical Center & Hospital Ltd is fundamentally a super-specialty hospital that trains its own doctors - it was the first corporate hospital in India to start a medical college, in 2019. The company began as a single 200-bed facility in Coimbatore in 1990 and has since grown into a 2,250-bed network across Tamil Nadu by repeatedly reinvesting in advanced clinical equipment and then building the teaching infrastructure to staff it. That pattern - buy the machine, master the procedure, then teach the next generation - explains how a regional hospital became a multi-organ transplant centre and the dominant quaternary-care provider for its catchment area. # Business segments Two engines that feed each other - a multi-location hospital network that delivers complex clinical care, and a medical college that supplies both talent and a high-volume general hospital - with the hospital generating nearly all the revenue. ## 1. Healthcare Services: where the group's clinical reputation is built **A quaternary-care hub in Coimbatore anchors a network of peripheral hospitals and a high-volume teaching hospital, earning fees for everything from robotic surgery to routine outpatient visits.** - **Complex procedures few others can do** - the main centre performs kidney, liver, heart, lung, bone marrow and pancreas transplants, and pioneered steroid-free kidney transplantation in India. In FY25 it completed a rare split liver transplant for two adult recipients, and has performed over 60 epilepsy surgeries since the COVID period, including the first documented epilepsy brain surgery on a pregnant woman in India. - **Equipment as a competitive edge** - the hospital houses a da Vinci Si Robotic Surgical System, a Varian Trilogy Linear Accelerator, a 3Tesla MRI, and a Truebeam Linear Accelerator with what was described as Asia's first hyperarc system for stereotactic radiosurgery. In FY24 it became the first hospital in India to introduce Siemen's 3D C-arm for fracture fixation, and the first in Tamil Nadu to deploy the EnSite X EP System for heart mapping. - **A low-cost, high-volume feeder** - the 750-bed Medical College General Hospital runs 16 operation theatres and provides 24x7 outpatient services across general medicine, paediatrics, surgery, obstetrics and more, operating on an affordable-care model that draws patients from across Western Tamil Nadu and parts of Kerala. - **Expanding the footprint** - the network includes peripheral centres in Coimbatore city, Sulur, Erode and Kovilpalayam, and the company is building a new hospital in Chennai. In early 2026 it also approved an expansion at Sulur and a new Children's Hospital at the main campus. - **Fee-for-service across every touchpoint** - revenue comes from inpatient room charges, procedures and surgeries, plus outpatient consultations and diagnostics, with inpatient services the dominant share. In FY25 the network handled 1,05,269 inpatients and 12,40,046 outpatients, with an average revenue per occupied bed of ₹22,581 and a bed occupancy rate of about 60%. ## 2. Education Services: the talent pipeline that sustains the clinical engine **A medical college established in 2019 produces MBBS graduates and specialists while its attached teaching hospital doubles as a community-care facility - though the allied-health division is being sold.** - **First-mover in corporate medical education** - KMCH Institute of Health Sciences and Research was the first medical college started by a corporate hospital in India, admitting its first MBBS batch in 2019-20 with an annual intake of 150 students, all seats filled each year. - **Teaching feeds the hospital** - the 750-bed Medical College General Hospital, opened in October 2021, provides the clinical training ground for students while simultaneously delivering 24x7 healthcare to the general public, creating a pipeline of doctors familiar with the KMCH system. - **Postgraduate expansion underway** - in January 2026 the company launched the KMCH Medical College Post Graduate Institute at the Coimbatore campus, adding capacity for advanced specialty training alongside the new neuro sciences block. - **Allied health division being carved out** - in May 2026 the Board approved the slump sale of the Allied Health Sciences courses to a related-party charitable trust for cash consideration, with completion subject to requisite consents, permissions and approvals; the division contributed only 0.29% of total turnover and had a negative net worth. # Group structure and partners **A single-entity, promoter-led public company with no subsidiaries, operating entirely within Tamil Nadu and funded by a mix of internal accruals and bank borrowings.** - **Standalone legal structure** - KMCH has no subsidiaries, joint ventures or associate companies, and no holding company; it operates as one public limited company listed on the Bombay Stock Exchange. - **Promoter-managed** - Dr. Nalla G Palaniswami serves as Managing Director, with Dr. Thavamani Devi Palaniswami as Joint Managing Director and Dr. Arun N Palaniswami as Executive Director, all from the promoter group. - **Debt-funded expansion** - rated CRISIL AA- (stable) long-term and CRISIL A1+ short-term, the company had term loans of roughly ₹150 crore from Indian Bank and ₹120 crore from Indian Overseas Bank as of December 2024, alongside letter-of-credit and bank-guarantee facilities. - **No geographic diversification** - all operations are within Tamil Nadu, with no international presence and no exports; foreign exchange earnings are limited to education fees from NRE accounts, which amounted to ₹672.62 lakhs in FY25.

Documents — Kovai Medical Center & Hospital Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/tv4jsx1mwyjk1xddoyhz48o7.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/cvor6f4ugfdwnpdv2jui6dxg.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/fp0wifen6ymhhaaamracwjyp.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/r8f57sg27onwy6bf3gfmup9s.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/botvvq27xo1dn7wuhef39942.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/5kjcasssx8y7x4yj09xs8esk.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/weronsipxt6v3tdxfr4nd203.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/yhk3qxk66lgp4yr66ygfhewd.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/aui6erdrbyjxmz6w31mdcvr8.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/ksp6qs7241kfwpkr170rjxdx.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/1os5jqzface51vkhrb0ntphi.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/r0ofuxjooo8gdf5xalybmp9c.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/sz9h0lf9chgs0imhos78b1a9.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/esw697eagiwcytq4bxx4znrk.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/gdtz7mh97azr22ror5ukf8hb.pdf